Pioneering the Localization of
Plasma Fractionation Processes
A significant portion of the country's therapeutic need for plasma-derived products requires achieving technological independence in the fractionation chain.
Nojin Biopharma, as one of the modern pillars of pharmaceutical biotechnology in the country, was established with the goal of achieving national self-sufficiency in the production of albumin and immunoglobulins. By replacing traditional methods and integrating modern membrane filtration knowledge, we strive to take a strategic step toward ensuring the country's pharmaceutical supply security and improving the quality of life for patients with special conditions.
.webp)
Self-Sufficiency Geography & Value Chain
Research & Production Infrastructure
The physical and scientific chain of Nojin Biopharma guarantees research and mass production of biological products through two parallel and coordinated arms. By bridging the academic environment and the industrial park, we manage the most advanced separation processes.
Industrial Plasma Fractionation Plant (Nazarabad)
Located in Sepehr Industrial Park, Nazarabad, Alborz; equipped with Class A cleanroom production lines, cryogenic stainless steel tanks, and multi-stage filtration systems for high-capacity plasma fractionation.
Advanced R&D Center (National Institute of Genetic Engineering)
Based on Pajouhesh Boulevard, adjacent to the National Institute of Genetic Engineering and Biotechnology (NIGEB); the focus center for Nojin scientists on simulating column chromatography processes and safe formulation of biological drugs.
Sustainability & Pharmaceutical Self-Sufficiency Indicators
Achieving one hundred percent sustainability in the domestic supply chain of plasma-derived products is the core of our operations. Nojin directly fulfills the country's patients' need for life-saving drugs:
Nojin Human Albumin
Sterile production of 20% albumin using advanced ultrafiltration; complete physicochemical stability throughout the usage period.
Human Immunoglobulin (IVIG)
Production of 2500mg intravenous immunoglobulin with high antibody concentration for treating various immunodeficiency diseases.
Corporate Governance & Scientific Structure of Nojin
The combination of governance background in the healthcare industry and specialized pharmaceutical knowledge is the strategic driving force of Nojin Biopharma's board of directors.
Dr. Mohammad Hossein Motevalli Khameneh
Doctor of Pharmacy, former head of the Food and Drug Administration Supply Chain Department, expert in biopharmaceutical logistics strategies and governance of the country's pharmaceutical product value chain.
Eng. Salman Sanei Kashani
Senior leader in the development of biotechnology infrastructure and plasma-derived products; a prominent expert in the establishment and management of physical and cleanroom automation projects.